Palmet Gün Atak

Asst. Prof. MD.

Palmet Gün Atak

Biochemistry Laboratory
Single Form Doctors

Areas of Interests

  • Lung Cancers
  • Minimally Invasive Surgery
  • Trachea Surgery

Advanced Diagnostic Precision for Safer, Faster, and Personalized Patient Care

Specialist Dr. Palmet Gün Atak is a distinguished Biochemistry Specialist at Liv Hospital, dedicated to ensuring that every patient receives accurate, clear, and reliable diagnostic support as part of their treatment journey. With comprehensive experience in high-volume clinical laboratories, she plays a vital role in patient care by overseeing the precise interpretation of laboratory results that guide clinical decision-making. Her approach centers on patient safety, advanced laboratory technology, and medical accuracy, ensuring that every test result contributes to the development of the most effective and personalized treatment plan.

Dr. Atak graduated from Hacettepe University Faculty of Medicine, one of Turkey’s leading medical institutions, and completed her specialization training at the Marmara University Faculty of Medicine, Department of Biochemistry. Over her career, she has held key roles at Şişli Florence Nightingale Hospital, Adıyaman Maternity and Children’s Hospital, and Marmara University Hospital before joining Liv Hospital in 2021. This experience allowed her to work across diverse patient groups and complex diagnostic challenges, helping her build deep expertise in clinical biochemistry and laboratory quality standards.

At Liv Hospital, Dr. Atak ensures that laboratory processes follow international best practices, enabling world-class diagnostics with high accuracy. She is committed to clear communication with patients and physicians, helping individuals understand laboratory results in a way that supports informed and confident health decisions. Her patient-centered philosophy prioritizes transparency, trust, and compassion, ensuring every patient feels supported throughout the diagnostic and treatment process.

Beyond her clinical role, Specialist Dr. Palmet Gün Atak is recognized for her academic contributions in the field of biochemistry, particularly in research focused on metabolic disorders, oxidative stress, and diagnostic biomarkers. She has authored multiple peer-reviewed scientific publications examining laboratory indicators in complex medical conditions, including diabetes, cardiovascular health, prenatal screening, genetic variations, and metabolic inflammation. Her research provides valuable insights that help align laboratory diagnostics with modern medical science and evolving clinical needs.

Dr. Atak is an active member of the Turkish Biochemistry Association, Turkish Clinical Biochemistry Association, and the Association of Clinical Biochemistry Specialists, where she continues to engage in scientific exchange, professional development, and academic collaboration. Through her ongoing research and participation in scientific meetings, she contributes to improving laboratory methodologies and enhancing diagnostic accuracy across healthcare settings.

Her role as both clinician and researcher ensures that patients at Liv Hospital benefit from evidence-based laboratory practices and the latest advancements in diagnostic science. With a dedication to accuracy, scientific rigor, and continuous improvement, Dr. Atak stands as a respected leader in biochemistry and laboratory medicine, supporting patient care every day through precise, meaningful, and scientifically grounded laboratory insight.

Advanced Diagnostic Precision for Safer, Faster, and Personalized Patient Care

Specialist Dr. Palmet Gün Atak is a distinguished Biochemistry Specialist at Liv Hospital, dedicated to ensuring that every patient receives accurate, clear, and reliable diagnostic support as part of their treatment journey. With comprehensive experience in high-volume clinical laboratories, she plays a vital role in patient care by overseeing the precise interpretation of laboratory results that guide clinical decision-making. Her approach centers on patient safety, advanced laboratory technology, and medical accuracy, ensuring that every test result contributes to the development of the most effective and personalized treatment plan.

Dr. Atak graduated from Hacettepe University Faculty of Medicine, one of Turkey’s leading medical institutions, and completed her specialization training at the Marmara University Faculty of Medicine, Department of Biochemistry. Over her career, she has held key roles at Şişli Florence Nightingale Hospital, Adıyaman Maternity and Children’s Hospital, and Marmara University Hospital before joining Liv Hospital in 2021. This experience allowed her to work across diverse patient groups and complex diagnostic challenges, helping her build deep expertise in clinical biochemistry and laboratory quality standards.

At Liv Hospital, Dr. Atak ensures that laboratory processes follow international best practices, enabling world-class diagnostics with high accuracy. She is committed to clear communication with patients and physicians, helping individuals understand laboratory results in a way that supports informed and confident health decisions. Her patient-centered philosophy prioritizes transparency, trust, and compassion, ensuring every patient feels supported throughout the diagnostic and treatment process.

Beyond her clinical role, Specialist Dr. Palmet Gün Atak is recognized for her academic contributions in the field of biochemistry, particularly in research focused on metabolic disorders, oxidative stress, and diagnostic biomarkers. She has authored multiple peer-reviewed scientific publications examining laboratory indicators in complex medical conditions, including diabetes, cardiovascular health, prenatal screening, genetic variations, and metabolic inflammation. Her research provides valuable insights that help align laboratory diagnostics with modern medical science and evolving clinical needs.

Dr. Atak is an active member of the Turkish Biochemistry Association, Turkish Clinical Biochemistry Association, and the Association of Clinical Biochemistry Specialists, where she continues to engage in scientific exchange, professional development, and academic collaboration. Through her ongoing research and participation in scientific meetings, she contributes to improving laboratory methodologies and enhancing diagnostic accuracy across healthcare settings.

Her role as both clinician and researcher ensures that patients at Liv Hospital benefit from evidence-based laboratory practices and the latest advancements in diagnostic science. With a dedication to accuracy, scientific rigor, and continuous improvement, Dr. Atak stands as a respected leader in biochemistry and laboratory medicine, supporting patient care every day through precise, meaningful, and scientifically grounded laboratory insight.

  • Necati Çitak, Yunus Aksoy, Özgür İşgörücü, Ciğdem Obuz, Barış Açıkmeşe, Songül Büyükkale, Neslihan Akalın Fener, Muzaffer Metin & Adnan Sayar  The prognostic impact of the mediastinal fat tissue invasion in patients with non-small cell lung cancer General Thoracic and Cardiovascular Surgery volume 69, pages76–83(2021)
  • Necati Citak, Yunus Aksoy, Özgür Isgörücü, Cigdem Obuz, Baris Acikmese, Songul Buyukkale, Muzaffer Metin, Adnan Sayar  A Comparison of the Currently Used Nodal Stage Classification with the Number of Metastatic Lymph Nodes and the Number of Metastatic Lymph Node Stations for Non-Small Cell Lung Cancer; Which of These Is the Best Prognostic Factor?[*] DOI: 10.1055/a-1008-9598
  • Derya Özden Omaygenç, Necati Çıtak, Özgür İşgörücü, Ayşe Ulukol, Songül Büyükkale, Çiğdem Obuz, Mustafa Vedat Doğru, Adnan Sayar  Comparison of Thoracic Epidural and Intravenous Analgesia from the Perspective of Recovery of Respiratory Function in the Early Post-Thoracotomy Period in Lung Cancer Surgery  DOI: 10.5152/TurkThoracJ.2021.19114
  • Yunus Aksoy , Necati Citak, Cigdem Obuz, Baris Acikmese, Atilla Pekcolaklar, Muzaffer Metin, Adnan Sayar  Prognostic Factors and Survival in Resected T4 Non-small Cell Lung Cancer: Is There Any Difference in the T4 Subgroups? DOI: 10.1055/a-1209-3668
  • Hasan Akın, Ali Cevat Kutluk, Çiğdem Obuz, Altan Ceritoğlu, Mehmet Uludağ, Nurcihan Aygün, Umutcan Kilimci, Nilgün Ulukol Surgical Treatment of A Tracheal Necrosis due to Mediastinitis after Thyroid Resection Turk Toraks Magazine DOI: 10.5152/TurkThoracJ.2019.311
  • Songül Büyükkale, Necati Çıtak, Özgür İşgörücü, Cem Emrah Kalafat, Yunus Aksoy, Çağrı Cemaller, Çiğdem Obuz, Barış Açıkmeşe, Ayşe Ulukol, Nur Dilek Bakan, Adalet Demir, Adnan Sayar Early period lung transplantation results of Yedikule Organ Transplantation Center: Our Three-Year Experience Turkish Journal of Thoracic and Cardiovascular Surgery 25 (1): 86-95 • January 2017
  • Necati Citak, Yunus Aksoy, Ozgur Isgorucu, Cigdem Obuz, Baris Acikmese, Songul Buyukkale, Neslihan Akanil Fener, Muzaffer, Muzaffer, Muzaffer Adnan Sayar, Does Mediastinal Fat Invasion Effect Survival of Patients with Lung Cancer? A Criticism on Forthcoming Eighth Edition of the TNM Classification of Non-Small Cell Lung Cancer American Journal of Respiratory and Critical Care Medicine 2020;201:A4900
  • Necati Çitak, Yunus Aksoy, Özgür İşgörücü, Çiğdem Obuz, Barış Açıkmeşe, Songül Buyukkale, Neslihan Akalın Fener, Muzaffer Metin, Adnan Sayar  Does Mediastinal Oily Tissue Invasion Affect Survival of Pathologic T Staging of Lung Cancer? Gen Thorac Cardiovasc Surg 2021 Jan;69(1):76-83. doi: 10.1007/s11748-020-01440-0.
  • Yunus Aksoy, Necati Çıtak, Özgür İşgörücü,  Çiğdem Obuz, Adnan Sayar The treatment of foreign body reaction and inflammation caused by prosthetic material with surgery and negative pressure wound therapy Current Thoracic Surgery DOI: 10.26663/cts.2019.00127
  • Yunus Aksoy, Çiğdem Obuz, Necati Çitak, Özgür İşgörücü, Songül Büyükkale, Adnan Sayar  Schwannoma Originating From the Periphereral Intercostal Nerves/ DOI: 10.4274/haseki.3364 Med Bull Haseki 2017;55:154-6
  • Necati Çitak, Yunus Aksoy, Özgür İşgörücü, Çiğdem Obuz, Barış Açıkmeşe, Songül Büyükkale, Muzaffer Metin, Adnan Sayar Used Nodal Evolution System, Metastasis Detected Statıon Or The Best Prognostic Factor In Small Cell Lung Cancer Dıseases Which Complete Response From Metastas Determıned Node?
  • The Role of PET-CT in Determining the Number of Metastatic Lymph Nodes in Operated Patients with Non-Small Cell Lung Cancer presented in Turkish Respiratory Society, 41th National Congress Of Respiratory Research/ oral presentation
  • Turkish Thoracic Surgery Association
  • Turkish Thoracic Association
  • Lung Health and Intensive Care Association
  • Turkish Respiratory Research Association
  • European Respiratory Society
  • European Society Of Thoracic Surgeons